Article
Evaluating the causal role of LEPR signaling in 16 cancers: A drug-target Mendelian randomization study.
Medicine - 10 Apr 2026
Chen Jihao, Yang Xuefei, Huang Ting, Zhou Heran
Abstract excerpt
The leptin receptor (LEPR) serves as a central regulator of energy balance and metabolic homeostasis, with growing interest in its pleiotropic roles in cancer. However, existing evidence on its oncogenic function remains ambiguous, with studies reporting both tumor-promoting and tumor-suppressive effects across different contexts. This duality complicates the interpretation of LEPR's precise role in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
